Analyst Ratings for Novartis (nvs)
nvs Rating Summary
nvs Price Target Summary
- Highest: $180.00 (TD Cowen)
- Lowest: $118.00 (Goldman Sachs)
- Average: $153.57
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$153.57 (-0.6%)
* Over Last 12-Mos
Rating Score: 3 / 10
Percentile Rank: 26%
Avg. $ Target:
$153.57 (-0.6%)
* Over Last 12-Mos
Rating Score: 3 / 10
Percentile Rank: 26%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/11/2026 | Argus | Jasper Hellweg | Upgrade | Buy (Hold) |
180.00 (N/A) |
161.59 (154.44) |
-4.42% | Details |
| 1/6/2026 | Barclays | Emmanuel Papadakis | Upgrade | Equalweight (Underweight) |
N/A (N/A) |
137.91 (154.44) |
11.99% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
